NIH drug development

Ketamine — A New Drug Treatment For Depression?

Remember ketamine, the old veterinary (and sometimes street) drug? Apparently it rapidly and significantly reduces anhedonia in those with treatment-resistant bipolar disorder, according to a new study. Anhedonia, which is a lack of interest in activities that once gave a person pleasure, is a key feature of treatment-resistant bipolar disorder. According to a recent NIH-funded …

Ketamine — A New Drug Treatment For Depression? Read More »

Now that NIH NCATS Is Replacing NCRR, Where Have The NCRR Programs Gone?

It has been over a year since NIH Director Francis Collins announced the creation of the National Center for Advancing Translational Science. From the NIH website:  “The goal of NCATS will be to develop new ways of doing translational research that the public and private research and development communities can adopt. Innovations that come out …

Now that NIH NCATS Is Replacing NCRR, Where Have The NCRR Programs Gone? Read More »

How Can I Help?

Let’s have a conversation about how I can help your faculty improve their NIH grantsmanship skills.
Contact Me
Shopping Cart
0
    0
    Your Cart
    Your cart is emptyReturn to Shop
    Continue Shopping